Form 4: Ulta Beauty CEO Receives Stock Grants and Options

Ulta Beauty's President and CEO, Kecia Steelman, was granted restricted stock and stock options on March 31, 2026, as detailed in a Form 4 filing.

Summary

• Kecia Steelman, President and CEO of Ulta Beauty, Inc., received a grant of 10,889 shares of restricted stock on March 31, 2026. This restricted stock is set to vest fully on March 15, 2029.
• Additionally, Steelman was granted stock options on the same date. These include options for 37,070 shares with an exercise price of $522.71, which will vest in 25% increments annually starting March 15, 2027, through March 15, 2030.
• Another grant of stock options for 68,000 shares, also with an exercise price of $522.71, was awarded. These performance-based options vest in two tranches based on achieving a Compound Annual Growth Rate (CAGR) of 8% and 18% in the stock price from a base price. Earned portions will service-vest on March 31, 2031, with unearned portions forfeited.
• Following these transactions, Steelman beneficially owns 42,489 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting standard executive compensation practices with incentives for future performance, but with no immediate financial results or strategic shifts disclosed.

Positives

• The CEO received significant equity awards, indicating continued investment in leadership and alignment with shareholder interests.
• The restricted stock grant provides a long-term incentive for the CEO, with full vesting in 2029.
• The stock options, particularly the performance-based ones, are designed to reward the CEO for achieving specific stock price growth targets.

Negatives

• The exercise price of the stock options ($522.71) is notably high, suggesting these options are only valuable if the stock price significantly increases from its current level.

Risks

• The performance-based stock options carry a risk of forfeiture if the company does not achieve the specified CAGR targets for stock price growth (8% and 18%).
• The vesting schedules for both restricted stock and options mean that the CEO's full benefit is contingent on continued employment and company performance over several years.

Future Outlook

The future outlook for the CEO's equity is tied to the company's stock performance, with specific targets for performance-based options and vesting schedules for restricted stock and other options extending up to 2036.

Industry Context

StockSavvy.ai notes that the granting of significant equity awards, including performance-based options, is a common practice in the retail sector to incentivize executive leadership and align their interests with long-term shareholder value creation, especially for a company like Ulta Beauty operating in a competitive beauty retail market.

Stakeholder Impact

• Shareholders: The grants align executive incentives with long-term stock performance, potentially benefiting shareholders if targets are met. However, the high exercise price of options means immediate dilution is not a concern, and value is only realized upon significant stock appreciation.
• Employees: While not directly impacted by these specific grants, such executive compensation structures can influence overall company morale and strategic direction.
• Management: The CEO's compensation is directly tied to future company performance and stock appreciation.

Next Steps

• Monitor the vesting of restricted stock and stock options based on the outlined schedules.
• Track the company's stock price performance against the CAGR targets for the performance-based options.

Key Dates

Keywords

Ulta Beauty, ULTA, Form 4, Kecia Steelman, Stock Options, Restricted Stock, Insider Trading, Executive Compensation, SEC Filing, Beneficial Ownership